Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Michał Osowiecki"'
Autor:
Ewa Paszkiewicz‐Kozik, Wojciech Michalski, Michał Taszner, Monika Mordak‐Domagała, Joanna Romejko‐Jarosińska, Wanda Knopińska‐Posłuszny, Jacek Najda, Anna Borawska, Monika Chełstowska, Monika Świerkowska, Anna Dąbrowska‐Iwanicka, Agata Malenda, Agnieszka Druzd‐Sitek, Robert Konecki, Beata Kumiega, Michał Osowiecki, Beata Ostrowska, Tomasz Szpila, Marcin Szymański, Łukasz Targoński, Katarzyna Domańska‐Czyż, Lidia Popławska, Sebastian Giebel, Andrzej Lange, Andrzej Pluta, Jan Maciej Zaucha, Grzegorz Rymkiewicz, Jan Walewski
Publikováno v:
British journal of haematology. 198(1)
The efficacy of salvage treatment of diffuse large B-cell lymphoma (DLBCL) patients who relapse or progress (rrDLBCL) after initial therapy is limited. Efficacy and safety of ofatumumab with iphosphamide, etoposide and cytarabine (O-IVAC) was evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46a3adce409650e263ac1017e0bc7013
https://pubmed.ncbi.nlm.nih.gov/35362096
https://pubmed.ncbi.nlm.nih.gov/35362096
Autor:
Joanna Romejko-Jarosinska, Beata Ostrowska, Anna Dabrowska-Iwanicka, Katarzyna Domanska-Czyz, Grzegorz Rymkiewicz, Ewa Paszkiewicz-Kozik, Robert Konecki, Anna Borawska, Agnieszka Druzd-Sitek, Elzbieta Lampka, Wlodzimierz Osiadacz, Michal Osowiecki, Lidia Popławska, Monika Swierkowska, Lukasz Targonski, Joanna Tajer, Grazyna Lapinska, Malwina Smorczewska, Jan Walewski
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Primary mediastinal B-cell lymphoma (PMBL) is currently curable in 85–95% of patients. Treatment regimens frequently used include RCHOP ± radiotherapy, DAEPOCH-R, or occasionally more intensive protocols. Here we present results of treatm
Externí odkaz:
https://doaj.org/article/390d2e0cb00f467e8bbd36aeef3cedd8
Publikováno v:
Leukemia & Lymphoma. 52:1604-1606
Rituximab in combination with chemotherapy significantly improves outcome compared to chemotherapy alone, and therefore it has become a new standard for the treatment of non-Hodgkin lymphomas (NHLs...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0145d6aadf533fcec5a0b5d57fec2b17
https://doi.org/10.3109/10428194.2011.574760
https://doi.org/10.3109/10428194.2011.574760